 Intravitreal injection of Bevacizumab in patients with Neovascular Membranes secondary to intraocular inflammation. We injected a single injection of Bevacizumab 2.5 mg0.1 ml and evaluate visual acuity , Fluorescein angiogram and retinal thickness by Optical Coherence Tomography OCT in 4 patients with Vogt Koyanagi Harada disease, 1 patient with Serpiginous Choroidopathy and 1 patient with Multifocal Choroiditis. 